Biological variability and specificity of lipoprotein-associated phospholipase A2 (Lp-PLA2), a novel marker of cardiovascular risk

被引：0
|
作者：
Wolfert, RL [1 ]
Kim, NW [1 ]
Selby, RG [1 ]
Sarno, MJ [1 ]
Warnick, RG [1 ]
Sudhir, K [1 ]
机构：
[1] diaDexus Inc, San Francisco, CA USA
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1477
引用
收藏
页码：309 / 309
页数：1
相关论文
共 50 条
  • [41] Study of the relationship between lipoprotein-associated phospholipase A2(Lp-PLA2) levels and coronary artery lesions
    Luo, Yanting
    Wu, Bingyuan
    Li, Suhua
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C100 - C101
  • [42] Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes
    Canning, Paul
    Kenny, Bridget-Ann
    Prise, Vivien
    Glenn, Josephine
    Sarker, Mosharraf H.
    Hudson, Natalie
    Brandt, Martin
    Lopez, Francisco J.
    Gale, David
    Luthert, Philip J.
    Adamson, Peter
    Turowski, Patric
    Stitt, Alan W.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (26) : 7213 - 7218
  • [43] Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Bound to LDL and HDL
    Tellis, Constantinos C.
    Tselepis, Alexandros D.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (40) : 6256 - 6269
  • [44] Lipoprotein-associated phospholipase A2 activity (Lp-PLA2) as a predictor of small-dense LDL particles
    Gazi, I.
    Tsimihodimos, V.
    Filippatos, T.
    Lourida, E.
    Elisaf, M.
    Tselepis, A.
    JOURNAL OF HYPERTENSION, 2006, 24 : S395 - S396
  • [45] Lipoprotein-associated phospholipase A2 (Lp-PLa2) is an independent predictor of adverse cardiovascular outcomes in patients with stable coronary artery disease
    Sabatine, Marc S.
    Morrow, David A.
    O'Donoghue, Michelle
    Jablonski, Kathleen A.
    Rice, Madeline M.
    Solomon, Scott D.
    Rosenberg, Yves D.
    Domanski, Michael J.
    Hsia, Judith
    CIRCULATION, 2006, 114 (18) : 713 - 713
  • [46] Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in Acute Coronary Syndrome: Relationship With Low-Density Lipoprotein Cholesterol
    Jabor, Bashar
    Choi, Hong
    Ruel, Isabelle
    Hafiane, Anouar
    Mourad, Walid
    Genest, Jacques
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (12) : 1679 - 1686
  • [47] Lipoprotein-associated phospholipase A2:: A risk marker or a risk factor?
    Lerman, Amir
    McConnell, Joseph P.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (12A): : 11F - 22F
  • [48] Lipoprotein-Associated Phospholipase A2 as a Novel Risk Marker for Cardiovascular Disease A Systematic Review of the Literature
    Madjid, Mohammad
    Ali, Muzammil
    Willerson, James T.
    TEXAS HEART INSTITUTE JOURNAL, 2010, 37 (01): : 25 - 39
  • [49] Lp-PLA2 (Lipoprotein-Associated Phospholipase A2) Deficiency Lowers Cholesterol Levels and Protects Against Atherosclerosis in Rabbits
    Chen, Jiahuan
    Zhang, Huanyu
    Li, Linquan
    Zhang, Xinwei
    Zhao, Dazhong
    Wang, Lingyu
    Wang, Jiaqi
    Yang, Ping
    Sun, Huan
    Liu, Kun
    Chen, Weiwei
    Li, Lin
    Lin, Feng
    Li, Zhanjun
    Chen, Y. Eugene
    Zhang, Jifeng
    Pang, Daxin
    Ouyang, Hongsheng
    He, Yuquan
    Fan, Jianglin
    Tang, Xiaochun
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43 (01) : E11 - E28
  • [50] EVEROLIMUS REDUCES ATHEROSCLEROSIS AND LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) SECRETION IN APOLIPOPROTEIN E KNOCKOUT MICE
    Sazonova, M. A. A. .
    Sazonova, M. D.
    Sinyov, V. V.
    Ryzhkova, A. I.
    Kirichenko, T. V.
    Doroschuk, N. A.
    Karagodin, V. P.
    Orekhov, A. N.
    Sobenin, I. A.
    ATHEROSCLEROSIS, 2021, 331 : E98 - E98
12345